No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life

  • Anne M. Plomgaard
  • , Thomas Alderliesten
  • , Frank van Bel
  • , Manon Benders
  • , Olivier Claris
  • , Malaika Cordeiro
  • , Eugene Dempsey
  • , Monica Fumagalli
  • , Christian Gluud
  • , Simon Hyttel-Sorensen
  • , Petra Lemmers
  • , Adelina Pellicer
  • , Gerhard Pichler
  • , Gorm Greisen

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Psychology

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology